3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 4
2
Phase EARLY_PHASE1
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
256
Breast Neoplasms
174
Neoplasms
169
Colorectal Neoplasms
153
Neoplasm Metastasis
127
Recurrence
120
Melanoma
120
Prostatic Neoplasms
118
Leukemia, Myeloid, Acute
117
Pancreatic Neoplasms
115
Ovarian Neoplasms
112
Multiple Myeloma
104
Lung Neoplasms
94
Stomach Neoplasms
92
Triple Negative Breast Neoplasms
86
Squamous Cell Carcinoma of Head and Neck
85
Glioblastoma
81
Lymphoma
77
Lymphoma, Non-Hodgkin
75
Lymphoma, Large B-Cell, Diffuse
65
Precursor Cell Lymphoblastic Leukemia-Lymphoma
64
Carcinoma, Renal Cell
64
Advanced Solid Tumor
59
Endometrial Neoplasms
58
Carcinoma, Hepatocellular
58
Small Cell Lung Carcinoma
56
Uterine Cervical Neoplasms
53
Sarcoma
53
Myelodysplastic Syndromes
51
Leukemia
50
Interventions
Raltegravir Potassium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Hepatitis B
×
1 year
×
Clear all
NCT01022476
2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2
Completed
14 enrolled